Category: Inflammation
-
“Smart” drug targets site-specific inflammation
Ben-Gurion University‘s Peleg Rider has developed a drug that targets inflammation in a site-specific manner. This could improve the body’s ability to fight infection and reduce side effects. When injected, it is a non-active drug. A localized site with excessive inflammation will activate it. Other anti-inflammatory agents inhibit inflammatory processes throughout the body, including sites of…